Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
1844 | 2 | ALPHA1 ADRENOCEPTOR SUBTYPE//ALPHA1 ADRENOCEPTOR//CHLOROETHYLCLONIDINE | 6467 |
32691 | 1 | HUHS1015//NAFTOPIDIL//DOXAZOSIN | 148 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | HUHS1015 | authKW | 1064763 | 3% | 100% | 5 |
2 | NAFTOPIDIL | authKW | 809754 | 11% | 22% | 17 |
3 | DOXAZOSIN | authKW | 486613 | 20% | 8% | 29 |
4 | ALPHA 1 ADRENERGIC DRUGS | authKW | 425905 | 1% | 100% | 2 |
5 | CAS 57149 07 2 | authKW | 425905 | 1% | 100% | 2 |
6 | NAFTOPIDIL ANALOGUE | authKW | 425905 | 1% | 100% | 2 |
7 | NAFTOPIDIL ENANTIOMERS | authKW | 283935 | 1% | 67% | 2 |
8 | TRANSPORT P | authKW | 283935 | 1% | 67% | 2 |
9 | ALPHA 1 ADRENOCEPTOR ANTAGONISTS | authKW | 243369 | 3% | 29% | 4 |
10 | 1 ADRENOCEPTOR ANTAGONISTS | authKW | 212953 | 1% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Urology & Nephrology | 952 | 24% | 0% | 35 |
2 | Pharmacology & Pharmacy | 410 | 32% | 0% | 47 |
3 | Oncology | 367 | 27% | 0% | 40 |
4 | Endocrinology & Metabolism | 59 | 9% | 0% | 13 |
5 | Chemistry, Medicinal | 27 | 5% | 0% | 7 |
6 | Medicine, Research & Experimental | 13 | 5% | 0% | 7 |
7 | Chemistry, Analytical | 12 | 5% | 0% | 8 |
8 | Cardiac & Cardiovascular System | 7 | 4% | 0% | 6 |
9 | Microscopy | 4 | 1% | 0% | 1 |
10 | Anatomy & Morphology | 2 | 1% | 0% | 1 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AREA INVEST DOCENCIACARDIOL UNIT | 212953 | 1% | 100% | 1 |
2 | CC BIOSANIARIAS | 212953 | 1% | 100% | 1 |
3 | HEAD OUTCOMES | 212953 | 1% | 100% | 1 |
4 | INVEST NUMERO 1UNIDAD INVESTSERV CARDIOL | 212953 | 1% | 100% | 1 |
5 | KENTUCKY CANC REGISTRYCANC BIOINFORMAT | 212953 | 1% | 100% | 1 |
6 | LIFE SCI BIOINFORMAT STRUCT BIOL | 212953 | 1% | 100% | 1 |
7 | MOL CELLULAR BIOCHEMCOMBS CANC | 212953 | 1% | 100% | 1 |
8 | NEPHRO UROL SURG ANDROL | 212953 | 1% | 100% | 1 |
9 | QUEENSLAND AUSTRALIA PHARM | 212953 | 1% | 100% | 1 |
10 | SURG MOL CELLULAR BIOCHEM | 212953 | 1% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTATE | 6611 | 8% | 0% | 12 |
2 | GENE THERAPY AND MOLECULAR BIOLOGY | 1530 | 1% | 1% | 1 |
3 | INTERNATIONAL NEUROUROLOGY JOURNAL | 908 | 1% | 0% | 1 |
4 | CURRENT CANCER DRUG TARGETS | 845 | 1% | 0% | 2 |
5 | RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY | 767 | 1% | 0% | 1 |
6 | BRITISH JOURNAL OF PHARMACOLOGY | 752 | 5% | 0% | 8 |
7 | PROSTATE CANCER AND PROSTATIC DISEASES | 748 | 1% | 0% | 2 |
8 | ANTICANCER RESEARCH | 691 | 5% | 0% | 8 |
9 | CANCER PREVENTION RESEARCH | 668 | 1% | 0% | 2 |
10 | INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH | 580 | 1% | 0% | 1 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HUHS1015 | 1064763 | 3% | 100% | 5 | Search HUHS1015 | Search HUHS1015 |
2 | NAFTOPIDIL | 809754 | 11% | 22% | 17 | Search NAFTOPIDIL | Search NAFTOPIDIL |
3 | DOXAZOSIN | 486613 | 20% | 8% | 29 | Search DOXAZOSIN | Search DOXAZOSIN |
4 | ALPHA 1 ADRENERGIC DRUGS | 425905 | 1% | 100% | 2 | Search ALPHA+1+ADRENERGIC+DRUGS | Search ALPHA+1+ADRENERGIC+DRUGS |
5 | CAS 57149 07 2 | 425905 | 1% | 100% | 2 | Search CAS+57149+07+2 | Search CAS+57149+07+2 |
6 | NAFTOPIDIL ANALOGUE | 425905 | 1% | 100% | 2 | Search NAFTOPIDIL+ANALOGUE | Search NAFTOPIDIL+ANALOGUE |
7 | NAFTOPIDIL ENANTIOMERS | 283935 | 1% | 67% | 2 | Search NAFTOPIDIL+ENANTIOMERS | Search NAFTOPIDIL+ENANTIOMERS |
8 | TRANSPORT P | 283935 | 1% | 67% | 2 | Search TRANSPORT+P | Search TRANSPORT+P |
9 | ALPHA 1 ADRENOCEPTOR ANTAGONISTS | 243369 | 3% | 29% | 4 | Search ALPHA+1+ADRENOCEPTOR+ANTAGONISTS | Search ALPHA+1+ADRENOCEPTOR+ANTAGONISTS |
10 | 1 ADRENOCEPTOR ANTAGONISTS | 212953 | 1% | 100% | 1 | Search 1+ADRENOCEPTOR+ANTAGONISTS | Search 1+ADRENOCEPTOR+ANTAGONISTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |